![Edward Albini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Albini
Plus aucun poste en cours
Fortune : 533 889 $ au 30/06/2026
Profil
Edward C.
Albini formerly worked at Genentech, Inc., as Director-Finance & International Operations, Lynx Therapeutics, Inc., as Chief Financial Officer from 1997 to 2004, Carbylan Therapeutics, Inc., as Chief Financial Officer, Itero Biopharmaceuticals, Inc., as Chief Financial Officer & Senior Vice President from 2009 to 2011, Sutro Biopharma, Inc., as Chief Financial Officer & Secretary from 2013 to 2025, Novacea, Inc., as Chief Financial Officer from 2004 to 2009, and Itero Holdings LLC, as Chief Financial Officer & Secretary from 2011 to 2016.
Mr. Albini received his undergraduate degree from Santa Clara University and Masters Business Admin degree from Haas School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/05/2025 | 16 081 ( 0,1% ) | 533 889 $ | 30/06/2026 |
Anciens postes connus de Edward Albini
| Sociétés | Poste | Fin |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Directeur Financier/CFO | 15/05/2025 |
Itero Holdings LLC
 Itero Holdings LLC Financial ConglomeratesFinance Provides investment services | Directeur Financier/CFO | 01/01/2016 |
Itero Biopharmaceuticals, Inc.
 Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for novel therapeutic proteins and antibodies | Directeur Financier/CFO | 01/01/2011 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Financier/CFO | 01/01/2009 |
Lynx Therapeutics, Inc.
 Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Directeur Financier/CFO | 01/02/2004 |
Formation de Edward Albini
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
38
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for novel therapeutic proteins and antibodies | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Itero Holdings LLC
Itero Holdings LLC Financial ConglomeratesFinance Provides investment services | Finance |
